Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Ciara Clancy

Interviews

Move to the beat: meet the Parkinson’s physio behind award-winning mobility app

Giving Parkinson’s patients “the tools to take control”

READ MORE
Roger Barker lead

Resources & Tools

Parkinson’s podcast: ‘New Neurons for Old’ – interview with Dr Roger Barker

The controversial history of foetal tissue and stem cell therapies

READ MORE
Well being map lead

Resources & Tools

Free online tool allows you to track Parkinson’s symptoms

Map out the frequency of motor and non-motor Parkinson’s symptoms

READ MORE